A study on the establishment of an endothelium-dependent vasodilatory response test as a medical indicator for atherosclerotic vascular disorders with a novel vascular endothelial function measuring device (pFMD).

A study on the establishment of an endothelium-dependent vasodilatory response test as a medical indicator for atherosclerotic vascular disorders with a novel vascular endothelial function measuring device (pFMD). - A study on the establishment of an endothelium-dependent vasodilatory response test as a medical indicator for atherosclerotic vascular disorders with a novel vascular endothelial function measuring device (pFMD).

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000057608

Enrollment

10000

Registered

2025-04-14

Start date

2025-02-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who have been seen by a cardiologist for a minimum of 6 months and whose condition is stable. Age 18 years and over.

Exclusion criteria

Exclusion criteria: (1) Age: under 18 (2) Cases where brachial anthemostasis is not possible (3) Cases where it is difficult to obtain written explanation and consent (4) Other cases deemed inappropriate by the physician

Design outcomes

Primary

Measure	Time frame
Infarction (fatal, non-fatal), bleeding in the computer (fatal, non-fatal), subclavian hemorrhage (fatal, non-fatal), recurrence of cardiac tachycardia (PCI, Bappas), infarction of the heart tendon (fatal, non-fatal), cardiac insufficiency (fatal, non-fatal), sudden death, aneurysm of large arteries, dissolution of large arteries (fatal, non-fatal), and occlusive arteries Sclerosis, Devastating neoplasm Translated with DeepL.com (free version)	—

Measure

Time frame

Infarction (fatal, non-fatal), bleeding in the computer (fatal, non-fatal), subclavian hemorrhage (fatal, non-fatal), recurrence of cardiac tachycardia (PCI, Bappas), infarction of the heart tendon (fatal, non-fatal), cardiac insufficiency (fatal, non-fatal), sudden death, aneurysm of large arteries, dissolution of large arteries (fatal, non-fatal), and occlusive arteries Sclerosis, Devastating neoplasm Translated with DeepL.com (free version)

—

Secondary

Measure	Time frame
pFMD, FMD, baPWV	—

Countries

Japan

Contacts

Public ContactShinji Kishimoto

Research Institute for Radiation Biology and Medicine, Hiroshima University Department of Regenerative Medicine, Division of Radiation Medical Science

skishimoto@hiroshima-u.ac.jp81-82-257-5831

Outcome results